Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Looks to add Lead Technical Centre in Nottingham in 2014
October 14, 2013
By: Gil Roth
President, Pharma & Biopharma Outsourcing Association
Aesica plans to increase its range of inhalation services and products in development, with a new Lead Technical Centre in Nottingham in the cards. The company has hired skilled staff in this area, worked on commercial development of several inhalation technologies, and is actively partnering with innovative companies and universities to discover and engineer new technologies for commercial applications. Aesica currently has two new development technologies available to clients, including spray drying techniques delivered through a partnership with Upperton, and a powder filling technology delivered through 3P’s Fill2Weight. The company’s Nottingham site has more than five years of experience developing new generic inhalation products alongside many NCEs for trial. Aesica is increasingly looking to work with clients over the longer term and is concentrating on taking new drug targets through to commercial stage, with the ability to switch easily between initial nebulized products, which permit for low-cost entry to early clinical trials, and dry powder inhalers for use in later clinical trials. Aesica’s management contends that the push into inhalation services responds to client demands for CDMOs to offer a wider range of development technologies, delivery expertise and the ability to take a project to commercialization. In addition, having a portfolio of non-IP-protected products, can enable a CDMO to work with clients on developing a formulation irrespective of delivery mechanism. Re-formulations of generic products is seen an area of strong growth. Ian Lafferty, site director for Aesica Nottingham, commented, “Inhalation is a rapidly growing market with many U.S. companies looking to bring NCE production to Europe, whilst we also see a dramatic growth for products going into China and SE Asia, particularly amongst generic formulations. We have largely operated under the radar in terms of inhalation products despite the wealth of new technologies coming to market here and our intention is to take a lead in bringing products to market faster and developing the next generation of technologies through our Lead Technical Centre.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !